Effects of multifaceted optimization management for chronic heart failure: a multicentre, randomized controlled study-Reference-Cited by-同舟云学术

Effects of multifaceted optimization management for chronic heart failure: a multicentre, randomized controlled study

Published:2022-09-30 Issue:1 Volume:10 Page:133-147
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Pan Guangming¹^ORCID,Ji Weiqiang²^ORCID,Wang Xia¹,Li Song¹,Zheng Chaoyang¹,Lyu Weihui¹,Feng Xiaoyan³,Xia Yu⁴,Xiong Zhihua⁵,Shan Haohong⁶,Yang Haiyu⁷,Zou Xu¹^ORCID

Affiliation:

1. Guangdong Provincial Hospital of Chinese Medicine; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou Guangdong China

2. The Second School of Clinical Medicine Guangzhou University of Chinese Medicine Guangzhou Guangdong China

3. Yangjiang Hospital of Traditional Chinese Medicine Yangjiang Guangdong China

4. Qingyuan Hospital of Traditional Chinese Medicine Qingyuan Guangdong China

5. Guangzhou Baiyun Hospital of Traditional Chinese Medicine Guangzhou Guangdong China

6. Guangzhou Zengcheng District Hospital of Traditional Chinese Medicine Guangzhou Guangdong China

7. Jiangmen Wuyi Hospital of Traditional Chinese Medicine Jiangmen Guangdong China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14170

Reference29 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Epidemiology of heart failure

3. Report on cardiovascular health and diseases burden in China: An updated summary of 2020;The Writing Committee of the Report on Cardiovascular Health and Diseases in China;Chinese Circ J,2021

4. Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China;Wang H;Chin J Cardiol,2019

5. Chinese guidelines for the diagnosis and treatment of heart failure 2018;Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association;Chin J Cardiol,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of optimized new Shengmai powder on cardiomyocyte apoptosis and ferroptosis in ischemic heart failure rats: The mediating role of phosphatidylinositol-3-kinase/protein kinase B/tumor protein 53 signaling pathway;Journal of Ethnopharmacology;2024-08